摘要
目的:筛选踝关节骨折临床路径中预防性应用抗菌药物的合理化用药方案。方法:回顾性分析我院2008-2010年204例踝关节骨折围手术期预防性应用抗菌药物的情况,筛选出磺苄西林钠、头孢呋辛钠、头孢孟多酯钠和头孢美唑钠4种抗菌药物进行成本-效果分析。结果:204例患者预防性应用抗菌药物使用率100%,术前0.5~2h用药44例(21.57%),平均用药时间(6.03±2.51)d。磺苄西林钠、头孢呋辛钠、头孢孟多酯钠和头孢美唑钠的成本分别为1987.20、892.56、3644.28、1241.28元,有效率分别为71.43%、87.50%、88.46%、97.50%,成本-效果比分别为2782.02、1020.07、4119.69、1273.11,头孢孟多酯钠和头孢美唑钠相对于头孢呋辛钠的增量成本-效果比分别是286637.50和3487.20。结论:实施踝关节骨折临床路径需要优化抗菌药物的预防性应用,头孢呋辛钠可作为较佳用药方案。
OBJECTIVE:To select the reasonable drug regimen of the prophylactic application of antibiotics in the clinical pathway of ankle joint fracture.METHODS:We investigated retrospectively perioperative prophylactic application of antibiotics in 204 cases of ankle joint fracture from 2008 to 2010 in our hospital.The cost-effectiveness analyses were performed among sulbenicillin sodium,cefuroxime sodium,cefamandole nafate and cefmetazole sodium.RESULTS:204 patients all received prophylactic antibiotics preoperatively.44 patients were given antibiotics 0.5 to 2 hours before surgery(21.57%);mean medication time was(6.03± 2.51)d.The costs of sulbenicillin sodium,cefuroxime sodium,cefamandole nafate and cefmetazole sodium were 1 987.20 yuan,892.56 yuan,3 644.28 yuan and 1 241.28 yuan,respectively;the effective rates were 71.43%,87.50%,88.46% and 97.50%,respectively;the cost-effectiveness ratios were 2 782.02,1 020.07,4 119.69 and 1 273.11,respectively.The incremental cost-effectiveness ratios of cefamandole nafate and cefmetazole sodium were 286 637.50 and 3 487.20 respectively as against cefuroxime sodium.CONCLUSIONS:The prophylactic application of antibiotics in clinical pathway of ankle joint fracture needs optimization,and cefuroxime sodium is the best proposal to prevent perioperative infection.
出处
《中国药房》
CAS
CSCD
北大核心
2011年第38期3573-3574,共2页
China Pharmacy
关键词
临床路径
踝关节骨折
抗菌药物
成本-效果分析
Clinical pathway
Ankle joint fracture
Antibiotics
Cost-effectiveness analysis